Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00877695 · ClinicalTrials.gov registry record · NA

Motiv82Change: an HIV Prevention Study for Young Latino Men

A NA study of HIV Infections, sponsored by Nova Southeastern University.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT00877695: Completed NA study of HIV Infections, sponsored by Nova Southeastern University.

NCT00877695 is a NA study of HIV Infections that has completed, run by Nova Southeastern University. The registered enrollment target is 200 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00877695, a NA study of HIV Infections, has completed, sponsored by Nova Southeastern University.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop and pilot test a culturally and developmentally tailored Motivational Enhancement Intervention (MEI) to reduce risky sex (unprotected anal sex and multiple partners) among young Hispanic men who have sex with men (YHMSM).

Conditions Studied

Interventions

  • BEHAVIORAL Entre Culturas: Navigating Culture, Identity, and HIV Risk

Study Locations (1)

Florida

  • Nova Southeastern University (Miami Office) - Miami

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2010-08
Est. Completion 2012-06
Phase NA

Sponsor

Nova Southeastern University

71 total trials

What the Registry Record Tells You About NCT00877695

The ClinicalTrials.gov registry entry for NCT00877695 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (55% lower). The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Entre Culturas: Navigating Culture, Identity, and HIV Risk is the first listed.

NCT00877695 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT00877695 about?

NCT00877695 is a clinical study titled "Motiv82Change: an HIV Prevention Study for Young Latino Men". The purpose of this study is to develop and pilot test a culturally and developmentally tailored Motivational Enhancement Intervention (MEI) to reduce risky sex (unprotected anal sex and multiple partners) among young Hispanic men who have sex with men (YHMSM).

What is the current status of trial NCT00877695?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2010-08. Estimated completion is 2012-06.

What conditions does trial NCT00877695 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00877695?

The interventions under investigation include: Entre Culturas: Navigating Culture, Identity, and HIV Risk (BEHAVIORAL).

Who is sponsoring clinical trial NCT00877695?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00877695 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.